Comparative pharmaco-economic analysis of using enzalutamide, abiraterone and cabazitaxel in post-docetaxel castration-resistant prostate cancer patients

Recently, an increase in the incidence of severe forms of prostate cancer, in particular castration-resistant prostate cancer (CRPC) has been noticed. Treatment of CRPC patients is associated with increasing expenses and thus impacts the healthcare budgets at various levels. The aim was to study the...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: N. K. Mazina (Autore), P. V. Mazin (Autore)
Natura: Libro
Pubblicazione: IRBIS LLC, 2017-11-01T00:00:00Z.
Soggetti:
Accesso online:Connect to this object online.
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!

Accesso online

Connect to this object online.

3rd Floor Main Library

Dettagli sul posseduto da 3rd Floor Main Library
Collocazione: A1234.567
Copia 1 Disponibile